These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 29302228)

  • 1. Cannabis, cannabinoids, and health.
    Lafaye G; Karila L; Blecha L; Benyamina A
    Dialogues Clin Neurosci; 2017 Sep; 19(3):309-316. PubMed ID: 29302228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
    van Amsterdam J; Brunt T; van den Brink W
    J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cannabis use and somatic consequences].
    Franchitto N
    Rev Prat; 2020 Jan; 70(1):69-77. PubMed ID: 32877036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosis and synthetic cannabinoids.
    Deng H; Verrico CD; Kosten TR; Nielsen DA
    Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.
    Bassir Nia A; Medrano B; Perkel C; Galynker I; Hurd YL
    J Psychopharmacol; 2016 Dec; 30(12):1321-1330. PubMed ID: 27462088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cannabis and cannabinoids as drugs].
    Khiabani HZ; Mørland J
    Tidsskr Nor Laegeforen; 2007 Mar; 127(5):579-82. PubMed ID: 17332810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis-associated psychosis: Neural substrate and clinical impact.
    Murray RM; Englund A; Abi-Dargham A; Lewis DA; Di Forti M; Davies C; Sherif M; McGuire P; D'Souza DC
    Neuropharmacology; 2017 Sep; 124():89-104. PubMed ID: 28634109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis and psychosis: what do we know and what should we do?
    Colizzi M; Murray R
    Br J Psychiatry; 2018 Apr; 212(4):195-196. PubMed ID: 29557759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relevance of Sex in the Association of Synthetic Cannabinoid Use With Psychosis and Agitation in an Inpatient Population.
    Bassir Nia A; Mann CL; Spriggs S; DeFrancisco DR; Carbonaro S; Parvez L; Galynker II; Perkel CA; Hurd YL
    J Clin Psychiatry; 2019 Jul; 80(4):. PubMed ID: 31265768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Cannabidiol Safety: A Review.
    Singh C; Rao K; Yadav N; Vashist Y; Chugh P; Bansal N; Minocha N
    Curr Drug Saf; 2023; 18(4):465-473. PubMed ID: 36056846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids.
    Heal DJ; Gosden J; Smith SL
    Front Psychiatry; 2024; 15():1322434. PubMed ID: 38915848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
    Krebs MO; Kebir O; Jay TM
    Eur J Pain; 2019 Aug; 23(7):1225-1233. PubMed ID: 30793421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical marijuana and the mind. More is known about the psychiatric risks than the benefits.
    Harv Ment Health Lett; 2010 Apr; 26(10):1-3. PubMed ID: 20499454
    [No Abstract]   [Full Text] [Related]  

  • 14. Potency trends of cannabis in Jamaica during the period of 2014 to 2020.
    Lindsay CM; Bernard KK; Hammond AM; Beckford S; Abel WD; Brown PD; Young LE
    Drug Test Anal; 2024 Feb; 16(2):174-186. PubMed ID: 37309060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective and physiological effects of oromucosal sprays containing cannabinoids (nabiximols): potentials and limitations for psychosis research.
    Schoedel KA; Harrison SJ
    Curr Pharm Des; 2012; 18(32):5008-14. PubMed ID: 22716155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology.
    Potter DJ; Clark P; Brown MB
    J Forensic Sci; 2008 Jan; 53(1):90-4. PubMed ID: 18279244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the mechanism whereby cannabis use increases risk of psychosis?
    Luzi S; Morrison PD; Powell J; di Forti M; Murray RM
    Neurotox Res; 2008 Oct; 14(2-3):105-12. PubMed ID: 19073418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation and antipsychotic effectiveness.
    Ricci V; Ceci F; Di Carlo F; Di Muzio I; Ciavoni L; Santangelo M; Di Salvo G; Pettorruso M; Martinotti G; Maina G
    Psychiatry Res; 2023 Feb; 320():115053. PubMed ID: 36682093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.
    Breijyeh Z; Jubeh B; Bufo SA; Karaman R; Scrano L
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33562446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical use of cannabis. Cannabidiol: a new light for schizophrenia?
    Deiana S
    Drug Test Anal; 2013 Jan; 5(1):46-51. PubMed ID: 23109356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.